Literature DB >> 32944924

Bone densitometry by Radiofrequency Echographic Multi-Spectrometry (REMS) in acromegaly patients.

Małgorzata Rolla1, Jowita Halupczok-Żyła2, Aleksandra Jawiarczyk-Przybyłowska2, Marek Bolanowski2.   

Abstract

INTRODUCTION: REMS (Radiofrequency Echographic Multi-Spectrometry) is a recently introduced non-ionizing technology employed in evaluation of osteoporosis. The aim of our study was to compare BMD (bone mineral density) in acromegaly patients and healthy controls by performing novel REMS densitometry. Second objective was to analyze the correlation between results of REMS and classical DXA (dual-energy X-ray absorptiometry) in acromegaly patients.
MATERIAL AND METHODS: We enrolled 33 patients with acromegaly (AG) and 24 controls (CG). The acromegaly patients were divided into 2 subgroups: well-controlled acromegaly (WCA) and surgery-cured acromegaly (SCA). REMS was performed in all participants, while DXA only in the acromegaly group. IGF-I and GH levels were measured in acromegaly patients.
RESULTS: BMD of the lumbar spine (LS) and the femoral neck (FN) obtained from REMS did not reveal significant differences between AG, CG, WCA and SCA. Similarly, there were no significant differences in BMD measured by DXA at the LS and at the FN between WCA and SCA. Significant positive correlations between IGF-I concentrations and BMD obtained from both REMS and DXA were detected in the AG and WCA. In the AG and WCA, there were positive correlations between T-scores and LS BMD obtained from both methods.
CONCLUSIONS: REMS could be a potential method in assessment of bone status in acromegaly. Further studies with participation of active disease patients are needed.

Entities:  

Keywords:  DXA; REMS; acromegaly; densitometry; osteoporosis

Year:  2020        PMID: 32944924     DOI: 10.5603/EP.a2020.0056

Source DB:  PubMed          Journal:  Endokrynol Pol        ISSN: 0423-104X            Impact factor:   1.582


  2 in total

1.  Reproducibility and Accuracy of the Radiofrequency Echographic Multi-Spectrometry for Femoral Mineral Density Estimation and Discriminative Power of the Femoral Fragility Score in Patients with Primary and Disuse-Related Osteoporosis.

Authors:  Piera Lalli; Claudia Mautino; Chiara Busso; Francesca Bardesono; Marco Di Monaco; Lorenzo Lippi; Marco Invernizzi; Marco Alessandro Minetto
Journal:  J Clin Med       Date:  2022-06-29       Impact factor: 4.964

2.  Trabecular Bone Score and Osteoprotegerin as Useful Tools in the Assessment of Bone Deterioration in Acromegaly.

Authors:  Aleksandra Jawiarczyk-Przybyłowska; Jowita Halupczok-Żyła; Joanna Syrycka; Agnieszka Zembska; Justyna Kuliczkowska-Płaksej; Marek Bolanowski
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-21       Impact factor: 6.055

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.